CPE Co-Authors Joint Stakeholder Statement on the First JCA Report
Joint Stakeholder Statement co-authored by CPE responding to the first Joint Clinical Assessment (JCA) report published under the EU Health Technology Assessment (HTA) Regulation.
Joint Stakeholder Statement co-authored by CPE responding to the first Joint Clinical Assessment (JCA) report published under the EU Health Technology Assessment (HTA) Regulation.
Peer-reviewed study on plain language summaries supporting patient involvement in HTA: NICE and CEEU pilots, findings, and 8 recommendations. Read More
CPE and EFPIA Oncology Platform evaluate NCCP alignment with EBCP across 6 EU countries with policy recommendations for national and European action. Read More
CPE infographic explains the EU Joint Clinical Assessment (JCA) process with 7 patient involvement touchpoints under the new HTA Regulation. Read More
CPE’s first in-person Annual Conference June 2025: interactive sessions on prevention, diagnostics, survivorship, and Calls to Action to reduce cancer inequalities. Read More
CPE’s June 2025 EU Parliament forum report: MEPs, OECD data, patient stories, and concrete actions to tackle cancer care inequalities across Europe. Read More
39 stakeholders call on EU HTA Coordination Group to adopt fit-for-purpose JCA methodology for ATMPs, recognising single-arm trials and real-world evidence. Read More
EAU, WFIPP, ICS, and CPE call on the European Commission to include incontinence as a co-morbidity in the EU Mental Health Strategy and fund research. Read More
CPE, MEPs, and researchers call on EU policymakers to harness Real-World Evidence to improve health outcomes, regulatory decisions, and access to medicines.
Read More
PCE and CPE’s February 2023 webinar report examines opportunities and challenges of the EU HTA Regulation with EC, MEPs, ESMO, EFPIA, and patient advocates. Read More